SCHEMBL31584093

SCHEMBL31584093

Cc1nn(C2CCN(C3CCN(C(=O)OC(C)(C)C)CC3)CC2)c2ccc(B3OC(C)(C)C(C)(C)O3)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.46
NR3C1 P04150 4/20 0.41
GPR119 Q8TDV5 5/20 0.40
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OGFRL1 Q5TC84 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
PARP1 P09874 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
CTSD P07339 1/20 0.35
CTSE P14091 1/20 0.35
BACE1 P56817 1/20 0.35
PIK3CA P42336 2/20 0.35
PIK3CG P48736 2/20 0.35
MTOR P42345 1/20 0.35
ATR Q13535 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31583380 0.82 GPR119 (0.44) USP30NR3C1GPR119OPRM1OPRD1
SCHEMBL10060693 0.80 GPR119 (0.60) USP30GPR119MAPT
SCHEMBL30858274 0.79 IRAK4 (0.37) PRMT5WDR77
SCHEMBL30483040 0.78 PRMT5 (0.45) USP30PRMT5WDR77BACE1
SCHEMBL2355889 0.78 PRMT5 (0.45) USP30PRMT5WDR77BACE1
SCHEMBL2800381 0.76 USP30 (0.44) USP30NR3C1GPR119KDM4EMAPT
SCHEMBL30186809 0.76 USP30 (0.51) USP30NR3C1GPR119PRMT5WDR77
SCHEMBL12471570 0.76 USP30 (0.49) USP30GPR119PRMT5WDR77KDM4E
SCHEMBL23546390 0.75 USP30 (0.45) USP30NR3C1GPR119KDM4EMAPT
SCHEMBL31583610 0.75 USP30 (0.56) USP30GPR119HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025106910-A1 DEGRADER MOLECULES TARGETING ANDROGEN RECEPTOR FLARE THERAPEUTICS INC. (US) 2025-05-22 WO disclosed